# Cabozantinib With Radiation Therapy for the Treatment of Sarcomas of the Extremities

> **NCT04220229** · PHASE1,PHASE2 · TERMINATED · sponsor: **University of Washington** · enrollment: 6 (actual)

## Conditions studied

- Sarcoma of the Extremity
- Stage I Soft Tissue Sarcoma of the Trunk and Extremities
- Stage IA Soft Tissue Sarcoma of the Trunk and Extremities
- Stage IB Soft Tissue Sarcoma of the Trunk and Extremities
- Stage II Soft Tissue Sarcoma of the Trunk and Extremities

## Interventions

- **DRUG:** Cabozantinib S-malate
- **RADIATION:** Radiation Therapy

## Key facts

- **NCT ID:** NCT04220229
- **Lead sponsor:** University of Washington
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2020-06-01
- **Primary completion:** 2024-04-05
- **Final completion:** 2024-10-31
- **Target enrollment:** 6 (ACTUAL)
- **Why stopped:** Terminated due to end of funding
- **Last updated:** 2025-07-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04220229

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04220229, "Cabozantinib With Radiation Therapy for the Treatment of Sarcomas of the Extremities". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT04220229. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*